Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Chianese-Bullock, Kimberly A.
53  Ergebnisse:
Personensuche X
?
1

Multipeptide vaccines for melanoma in the adjuvant setting:..:

Ninmer, Emily K. ; Zhu, Hong ; Chianese-Bullock, Kimberly A....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Stability of Multi-Peptide Vaccines in Conditions Enabling ..:

Ashkani, Emily G. ; McKenna, Brian D. ; Bryant, Jennifer L....
International Journal of Peptide Research and Therapeutics.  30 (2024)  4 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
3

Phase I/II clinical trial of a helper peptide vaccine plus ..:

Vavolizza, Rick D ; Petroni, Gina R ; Mauldin, Ileana S...
Journal for ImmunoTherapy of Cancer.  10 (2022)  9 - p. e005424 , 2022
Link: https://doi.org/10.1136/..
 
?
4

Trial to evaluate the immunogenicity and safety of a melano..:

Slingluff, Jr., Craig L ; Petroni, Gina R ; Chianese-Bullock, Kimberly A...
Journal for ImmunoTherapy of Cancer.  9 (2021)  1 - p. e000934 , 2021
Link: https://doi.org/10.1136/..
 
?
5

Immunogenicity in humans of a transdermal multipeptide mela..:

Meneveau, Max O ; Petroni, Gina R ; Salerno, Elise P...
Journal for ImmunoTherapy of Cancer.  9 (2021)  5 - p. e002214 , 2021
Link: https://doi.org/10.1136/..
 
?
6

Phase I/II trial of a long peptide vaccine (LPV7) plus toll..:

Patel, Sapna P ; Petroni, Gina R ; Roszik, Jason...
Journal for ImmunoTherapy of Cancer.  9 (2021)  8 - p. e003220 , 2021
Link: https://doi.org/10.1136/..
 
?
7

MHC-restricted phosphopeptide antigens: preclinical validat..:

Engelhard, Victor H ; Obeng, Rebecca C ; Cummings, Kara L...
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000262 , 2020
Link: https://doi.org/10.1136/..
 
?
8

A multipeptide vaccine plus toll-like receptor agonists LPS..:

Melssen, Marit M. ; Petroni, Gina R. ; Chianese-Bullock, Kimberly A....
Journal for ImmunoTherapy of Cancer.  7 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
9

A randomized pilot trial testing the safety and immunologic..:

Slingluff Jr, Craig L. ; Petroni, Gina R. ; Olson, Walter C....
Cancer Immunology, Immunotherapy.  65 (2015)  1 - p. 25-36 , 2015
Link: https://doi.org/10.1007/..
 
?
10

Immunologic hierarchy, class II MHC promiscuity, and epitop..:

Hu, Yinin ; Petroni, Gina R. ; Olson, Walter C....
Cancer Immunology, Immunotherapy.  63 (2014)  8 - p. 779-786 , 2014
Link: https://doi.org/10.1007/..
 
?
11

Activation, dysfunction and retention of T cells in vaccine..:

Salerno, Elise P. ; Shea, Sofia M. ; Olson, Walter C....
Cancer Immunology, Immunotherapy.  62 (2013)  7 - p. 1149-1159 , 2013
Link: https://doi.org/10.1007/..
 
?
12

A multi-epitope melanoma helper peptide vaccine durably inc..:

Dillon, Patrick M ; Olson, Walter C ; Czarkowski, Andrea...
Journal for ImmunoTherapy of Cancer.  1 (2013)  S1 - p. , 2013
Link: https://doi.org/10.1186/..
 
?
13

Usefulness of prestudy assessment of patient willingness to..:

Judge, Joshua M ; Chianese-Bullock, Kimberly A ; Schroen, Anneke T.
Clinical Trials.  10 (2012)  1 - p. 143-150 , 2012
Link: https://doi.org/10.1177/..
 
?
14

Shipping blood to a central laboratory in multicenter clini..:

Olson, Walter C ; Smolkin, Mark E ; Farris, Erin M...
Journal of Translational Medicine.  9 (2011)  1 - p. , 2011
Link: https://doi.org/10.1186/..
 
?
15

Multi-peptide vaccines vialed as peptide mixtures can be st..:

Chianese-Bullock, Kimberly A. ; Lewis, Sarah T. ; Sherman, Nicholas E...
Vaccine.  27 (2009)  11 - p. 1764-1770 , 2009
Link: https://doi.org/10.1016/..
 
1-15